А.Г. Янковой, Л.Е. Гуревич, Е.В. Беспалова
Отделение трансплантологии и диализа ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского», Москва
1. Stewart J.H., Vajdic C.M., van Leeuwen M.T. The pattern of excess cancer in dialysis and transplantation. Nephrol. Dial. Transplant. 2009;24(10):3225–3231. 2. Suson K.D., Sausville J.E., Sener A., Phelan M.W. Native nephrectomy for renal cell carcinoma in transplant recipients. Transplantation. 2011;91:1376–1379. 3. Schwarz A., Vatandaslar S., Merkel S., Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin. J. Am. Soc. Nephrol. 2007;2:750–756. 4. Alexander M.P., Farag Y.M., Mittal B.V. De novo multifocal renal cell carcinoma in the renal allograft. Kidney Int. 2009;75:111–114. 5. Dunnill M.S., Millard P.R., Oliven D. Acquired cystic disease of the kidney: a hazard of long-term intermittent maintenance haemodialysis. J. Clin. Pathol. 1977;30:867–877. 6. Kojima Y., Takahara S., Miyake O., Nonomura N., Morimoto A. Renal cell carcinoma in dialysis patients: a single center experience. Int. J. Urol. 2006;13:1045–1048. 7. Matson M.A., Cohen E.P. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine (Baltimore).1990;69:217–226. 8. Kliem V., Kolditz M., Behrend M., Ehlerding G., Pichlmayr R., Koch KM., Brunkhorst R. Risk of renal cell carcinoma after kidney transplantation. Clin. Transplant. 1997;11:255–258. 9. Scandling J.D. Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening? Clin. J. Am. Soc. Nephrol., 2007;2:621–625. 10. Moudouni S.M., Lakmichi A., Tligui M., Rafii A., Tchala K., Haab F. Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int. 2006;98:298–302. 11. Ianhez L.E., Lucon M., Nahas W.C., Sabbaga E., Saldanha L.B., Lucon A.M. Renal cell carcinoma in renal transplant patients. Urology. 2007;69:462–464. 12. Ishikawa I., Hayama S., Morita K., Nakazawa T., Yokoyama H., Honda R. Long-term natural history of acquired cystic disease of the kidney. Ther. Apher. Dial. 2010;14:409–416. 13. Endo K., Okano R., Kuroda Y., Yamada S., Tabei K. Renal cell carcinoma with skull base metastasis preceded by paraneoplastic signs in a chronic hemodialysis patient. Intern. Med. 2001;40;924–930. 14. Stewart Fleming Renal cell carcinoma in acquired cystic kidney disease. Histopathology 2010;56:395–400. 15. Konda R., Sato H., Hatafuku F., Nozawa T., Ioritani N., Fujioka T. Expression of hepatocyte growth factor and its receptor C-met inacquired renal cystic disease associated with renal cell carcinoma. J. Urol. 2004;1:2166–2170. 16. Hoshida Y., Nakanishi H., Shin M., Satoh T., Hanai J., Aozasa K. Renal neoplasia in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutation. Transplantation. 1999;68:385–390. 17. Hughson M.D., Buchwald D., Fox M. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch. Pathol. Lab. Med. 1986;110:592–601. 18. Heinz-Peer G., Schoder M., Rand T., Mayer G., Mostbeck G.H. Prevalence of acquired cystic kidney disease and tumors in native kidneys of renal transplant recipients: a prospective US study. Radiology.1995;195(3):667–671. 19. Ishikawa I., Honda R., Yamada Y., Kakuma T. Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients. Ther. Apher. Dial. 2004;8:468–473. 20. Hyung Ho Lee., Kyung Hwa Choi., Seung Choul Yang., Woong Kyu Han. Renal Cell Carcinoma in Kidney Transplant Recipients and Dialysis Patients. Korean. J. Urol. 2012;53(4):229–233. 21. Goh A., Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am. J. Transplant. 2011;11:86–92. 22. Hoshida Y., Tsukuma H., Yasunaga Y. Cancer risk after renal transplantation in Japan. Int. J. Cancer. 1997;71:517–520. 23. Chi Yuen Cheung., Man Fai Lam., King Chung Lee. Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature. International Urology and Nephrology. 2011;43(3):675–680. 24. Neuzillet Y., Lay F., Luccioni A. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer. 2005;103:251–257. 25. Campbell S.C., Novick A.C., Belldegrun A. Guideline for management of the clinical T1 renal mass. J. Urol. 2009;182:1271–1279. 26. Campistol J.M. Minimizing the risk of posttransplant malignancy. Transplantation. 2009;87:19–22. 27. Grantham J.J. Acquired cystic kidney disease. Kidney Int. 1991;40:143–152. 28. Warren K.S., McFarlane J. The Bosniak classification of renal cystic masses. BJU Int. 2005;95(7);939–942. 29. Klatte T., Seitz C., Waldert M., de Martino M., Kikic Z., Böhmig G.A., Haitel A., Schmidbauer J., Marberger M., Remzi M. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int. 2010;105(9):1260–1265. 30. Moudouni S.M., Lakmichi A., Tligui M. Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int. 2006;98:298–302.
Янковой А.Г. – д.м.н., ведущий научный сотрудник хирургического отделения трансплантологии и диализа ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского», Москва.
Е-mail: 48yankovoy@mail.ru
Гуревич Л.Е. – д.б.н., профессор, главный научный сотрудник патологоанатомического отделения ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского», Москва.
Е-mail: larisgur@mail.ru
Беспалова Е.В. – врач-патологоанатом патологоанатомического отделения ГБУЗ МО «МОНИКИ им. М.Ф. Владимирского», Москва.